ArticleFrontiers in neurology2025
Improving epilepsy monitoring using long-term, in-home-bi-modal seizure monitoring device: clinical utilities and obstacles from a pilot study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patient-independent automated pediatric seizure monitoring based on expert-labeled electrographic ictal data as core reference knowledge.Clinical and experimental pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Our study aimed to evaluate a long-term, in-home, bi-modal wearable device for seizure monitoring in epilepsy patients, assessing its applicability, clinical utility and identifying obstacles in real-life settings. Methods: A prospective pilot study involved 14 epilepsy patients at Seoul National University Bundang Hospital from May 26, 2021, to January 31, 2022. Patients used a wearable device developed for the study, featuring four-channel electroencephalogram and accelerometer sensors. Neurologists provided instructions for device usage, and bi-modal signals were recorded during daily activities. Seizures were annotated through comprehensive data review, and clinical suggestion was provided based on annotated daily seizure frequency, identification of different seizure types, and monitoring seizure patterns throughout the day. Results: Nine patients (64.3%) used the device for over 100 h, totaling 3,724 h of monitoring and capturing 1,609 seizures. The device successfully recorded various seizure types, including focal, focal with bilateral spread and generalized/bilateral onset which were further annotated by reviewers. Based on the annotated data, we were able to provide clinical suggestions based on number of seizures, identification of ambiguous seizures and monitoring of diurnal seizure pattern. Device discontinuation factors included skin irritation, patients' unwillingness due to device appearance, and caregivers' reluctance to use the device. Conclusion: This study demonstrates the feasibility and clinical utility of a long-term, in-home, bi-modal wearable device for seizure monitoring in epilepsy patients. The long-term data recorded by the device provided valuable clinical insights, facilitating different treatment suggestions. Addressing issues such as device comfort, appearance, and ease of use is essential for enhancing patient and caregiver adherence. The findings support the potential of wearable technology to improve epilepsy management through seizure monitoring in real-life setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.